CD8A and Epstein-Barr virus infection: In the present work, we set out to detect CD8+ T cell responses against these “first wave” transforming proteins, to identify their target epitopes and HLA restricting alleles, and to determine how well they recognised B cells in the days following EBV infection, comparing such recognition with that shown by CD8+ T cells against the other two sources of candidate vaccine antigens.